Zepp Health Corporation reported its financial results for the first quarter of 2025, revealing a revenue of $38.5 million, which marks a 3.6% decline from the first quarter of 2024. This decrease was primarily attributed to a $5.0 million reduction in the sales of Xiaomi wearable products. However, the sales of Amazfit-branded products showed a positive growth trend with a 10.2% increase year over year. The company experienced a net loss of $19.7 million for the first quarter of 2025, compared to a net loss of $14.8 million in the corresponding period of 2024. The adjusted net loss, which excludes specific non-GAAP adjustments, stood at $18.1 million, a rise from the adjusted net loss of $13.6 million in the first quarter of 2024. Looking ahead, Zepp Health projects second-quarter revenues to range between $50 million and $55 million, indicating an anticipated growth of 23% to 35% compared to the second quarter of 2024. The company also highlighted a significant shift in its debt structure, with long-term borrowings now comprising about 70% of the total debt, following the retirement of $67.8 million of debt since early 2023 and an additional $11.5 million repaid in the first quarter of 2025. The ongoing share-repurchase program reflects confidence in the company's future outlook.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.